Loading data for FLRY3.SA — first visit, this takes a few seconds.

Fleury S.A.

São Paulo: FLRY3.SA · Real-Time Price · USD
19.21
-0.47 (-2.39%)
At close: Sep 02, 2026, 8:05 PM

The price, the headline numbers and the latest news, in one place.

Fleury S.A. (FLRY3.SA) Stock Price, Analysis & Data

No data available

Bid19.21
Market Cap10.7B
Revenue (ttm)8.79B
Net Income (ttm)704M
0.00
1.16
16.96
13
P/B (ttm)2.14
P/S (ttm)1.22
Earnings DateNov 5, 2026
Ask19.28
Volume4,077,100
Avg. Volume (20D)2,917,443
Open19.40
Previous Close19.68
Day's Range19.01 - 19.72
52-Week Range13.90 - 19.73
Analystn/a
Price Targetn/a
Dividends$1.61 (8.38%)
Ex-Dividend DateAug 12, 2026

About FLRY3.SA

Fleury S.A., together with its subsidiaries, engages in the provision of diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides medical services in the areas of diagnostics, laboratory support, infusions, clinical analyses, health management, healthcare, assistance medicine, orthopedics, ophthalmology, toxicological tes...

Sector Healthcare
IPO Date Dec 17, 2009
Employees 28,000
Stock Exchange São Paulo
Ticker Symbol FLRY3.SA
Full Company Profile

Financial Performance

In 2025, Fleury S.A.'s revenue was 8.29B, an increase of 7.89% compared to the previous year's 7.68B. Earnings were 612.83M, a decrease of -0.54%.

Financial numbers in BRL Financial Statements

Earnings Surprise

Fleury S.A. has released their quarterly earnings on Aug 6, 2026:
  • Revenue of $2.22B misses estimates by $0, with 10.32% YoY growth.
  • EPS of 0.41 exceeds estimates by 0.06, with 46.43% YoY growth.
Fleury S.A. is scheduled to release its earnings on Nov 5, 2026, during market hours.
Analysts project revenue of ... Upgrade